CellSeed (TSE:7776) Cyclically Adjusted PB Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7776 CellSeed Inc TSE:7776
51 GF Score
Price 円229.00
GF Value 円150.69
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is CellSeed Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CellSeed  (TSE:7776) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CellSeed Cyclically Adjusted PB Ratio Related Terms


CellSeed Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for CellSeed's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSeed Cyclically Adjusted PB Ratio Chart

CellSeed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 1.01 1.90 3.39 2.80

CellSeed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.16 4.07 2.50 2.99 2.33

TSE:7776 vs VRTX, REGN, MRNA: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, CellSeed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSeed Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSeed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CellSeed's Cyclically Adjusted PB Ratio falls into.


TSE:7776
51GF Score
CellSeed Inc TSE:7776
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSeed Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CellSeed's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, CellSeed's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=45.118/113.6000*113.6000
=45.118

Current CPI (Jun. 2026) = 113.6000.

CellSeed Quarterly Data

Book Value per Share CPI Adj_Book
201609 201.460 98.000 233.529
201612 126.374 98.400 145.895
201703 124.333 98.100 143.978
201706 131.322 98.500 151.454
201709 124.113 98.800 142.705
201712 110.166 99.400 125.904
201803 100.035 99.200 114.556
201806 106.424 99.200 121.873
201809 102.167 99.900 116.178
201812 123.200 99.700 140.376
201903 109.621 99.700 124.904
201906 94.980 99.800 108.114
201909 89.730 100.100 101.831
201912 103.669 100.500 117.182
202003 100.294 100.300 113.593
202006 104.291 99.900 118.593
202009 91.693 99.900 104.268
202012 95.350 99.300 109.081
202103 85.354 99.900 97.059
202106 80.092 99.500 91.442
202109 69.965 100.100 79.401
202112 57.836 100.100 65.636
202203 51.207 101.100 57.538
202206 58.647 101.800 65.445
202209 48.811 103.100 53.782
202212 48.248 104.100 52.651
202303 58.927 104.400 64.120
202306 59.270 105.200 64.003
202309 72.871 106.200 77.949
202312 68.811 106.800 73.192
202403 64.751 107.200 68.617
202406 63.295 108.200 66.454
202409 67.388 108.900 70.296
202412 62.401 110.700 64.036
202503 51.008 111.100 52.156
202506 43.640 111.700 44.382
202509 37.829 112.000 38.369
202512 35.671 113.000 35.860
202603 51.484 112.700 51.895
202606 45.118 113.600 45.118

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is CellSeed (TSE:7776) Overvalued in 2026?

Based on GuruFocus' analysis, CellSeed stock appears to be overvalued. The current stock price of 円229.00 is trading 52% above its estimated GF Value™ of 円150.69. GuruFocus considers CellSeed to be Significantly Overvalued.

Key valuation signals for TSE:7776:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: 円150.69 vs. price of 円229.00 (52% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the TSE:7776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CellSeed Business Description

Address 2-5-10 Aomi, Telecom Center Building, 15th Floor (East Wing, Koto-ku, Tokyo, JPN, 135-0064
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheets for corneal and esophageal regeneration; regenerated cardiac patches to treat heart diseases; cell sheets for periodontal tissue regeneration; and regenerated cartilage sheets for the treatment of osteoarthritis.
51GF Score

Get the complete analysis for TSE:7776

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円229.00
Price
円150.69
GF Value